In 2024, a Deloitte report revealed that 83% of life sciences and healthcare C-suite executives consider improving health equity as a top-10 goal. Additionally, 47% of them plan to increase health equity investments. The report highlights factors influencing health equity, including AI, regulatory pressures, patient engagement, and awareness of social determinants. Challenges include budget constraints and workforce staffing issues. Deloitte recommends setting measurable goals. The report also emphasizes the importance of addressing potential biases in AI, increasing community engagement, expanding workforce recruitment efforts, fostering ecosystem collaborations, and prioritizing research capabilities to advance health equity.
Source: MedCityNews
Keine Kommentare:
Kommentar veröffentlichen